David A. Cooney

Metabolism and action of amino acid analog anti-cancer agents.

J. Grem, D. Cooney, Z. Hao, 1990, Pharmacology & therapeutics.

Replication of human immunodeficiency virus in monocytes. Granulocyte/macrophage colony-stimulating factor (GM-CSF) potentiates viral production yet enhances the antiviral effect mediated by 3'-azido- 2'3'-dideoxythymidine (AZT) and other dideoxynucleoside congeners of thymidine

D. S. Webb, H. Mitsuya, S. Broder, 1989, The Journal of experimental medicine.

Effects of bone marrow stimulatory cytokines on human immunodeficiency virus replication and the antiviral activity of dideoxynucleosides in cultures of monocyte/macrophages.

A. Foli, S. Broder, C. Perno, 1992, Blood.

Inhibition of human immunodeficiency virus type 1 integrase by 3'-azido-3'-deoxythymidylate.

Y. Pommier, R. Agbaria, A. Mazumder, 1994, Proceedings of the National Academy of Sciences of the United States of America.

Resistance to cyclopentenylcytosine in murine leukemia L1210 cells.

D. Cooney, M. Zhang, D. Johns, 1993, Cancer research.

Initial studies on the cellular pharmacology of 2',3-dideoxycytidine, an inhibitor of HTLV-III infectivity.

S. Broder, J. Balzarini, D. Cooney, 1986, Biochemical pharmacology.

Potent and selective anti-HTLV-III/LAV activity of 2',3'-dideoxycytidinene, the 2',3'-unsaturated derivative of 2',3'-dideoxycytidine.

E. De Clercq, R. Pauwels, P. Herdewijn, 1986, Biochemical and biophysical research communications.

Relationships between the cytotoxicity of tiazofurin and its metabolism by cultured human lung cancer cells.

D. Carney, D. Cooney, H. Jayaram, 1985, The Journal of clinical investigation.

Conversion of 2-beta-D-ribofuranosylselenazole-4-carboxamide to an analogue of NAD with potent IMP dehydrogenase-inhibitory properties.

R. K. Robins, V. Marquez, D. Cooney, 1982, Biochemical pharmacology.